GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Purchase Of Property, Plant, Equipment

BCAL Diagnostics (ASX:BDX) Purchase Of Property, Plant, Equipment : A$-0.45 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Purchase Of Property, Plant, Equipment?

BCAL Diagnostics's purchase of property, plant, equipment for the six months ended in Dec. 2023 was A$-0.13 Mil. It means BCAL Diagnostics spent A$0.13 Mil on purchasing property, plant, equipment. BCAL Diagnostics's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.45Mil.

Compared with last quarter (A$-0.32 Mil in Jun. 2023 ), BCAL Diagnostics spent less money on purchasing property, plant, equipment in Dec. 2023 (A$-0.13 Mil).


BCAL Diagnostics Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for BCAL Diagnostics's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Purchase Of Property, Plant, Equipment Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Purchase Of Property, Plant, Equipment
-0.03 -0.36

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial -0.14 0.11 -0.04 -0.32 -0.13

BCAL Diagnostics Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BCAL Diagnostics Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


BCAL Diagnostics (ASX:BDX) Business Description

Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.